CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
lifesciencesreview
US
EUROPE
APAC
CANADA
  • US
    • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Home
  • Contributors
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • News

Recommended picks

How Data Science is Revolutionizing Genomics

How Data Science is Revolutionizing...

Human-specific Proteins Uncovered by Exploring Genetic Uncharted Territory

Human-specific Proteins Uncovered by...

A Broader Perspective of Genomics

A Broader Perspective of Genomics

The Future Of Genomics In Theory-Focused Approaches

The Future Of Genomics In...

Role of Human Genomic Data in Future

Role of Human Genomic Data in Future

Essentiality of Single-cell Genomics Technology

Essentiality of Single-cell Genomics...

Tactics to Handle Genomic Data

Tactics to Handle Genomic Data

Benefits of Advanced Genomic Testing

Benefits of Advanced Genomic Testing

How Data Science is Revolutionizing Genomics

How Data Science is Revolutionizing...

Human-specific Proteins Uncovered by Exploring Genetic Uncharted Territory

Human-specific Proteins Uncovered by...

A Broader Perspective of Genomics

A Broader Perspective of Genomics

The Future Of Genomics In Theory-Focused Approaches

The Future Of Genomics In...

Role of Human Genomic Data in Future

Role of Human Genomic Data in Future

Essentiality of Single-cell Genomics Technology

Essentiality of Single-cell Genomics...

Tactics to Handle Genomic Data

Tactics to Handle Genomic Data

Benefits of Advanced Genomic Testing

Benefits of Advanced Genomic Testing

Singapore to grow into a global hub of biotechnology

Life Sciences Review | Thursday, March 03, 2022
Tweet

10x Genomics just built its first production and commercial location outside of the United States in Singapore. It also includes automated production suites for reagent manufacturing.


FREMONT, CA: In Singapore, 10x Genomics has opened its first production and commercial facility outside of the United States. There are also automated production suites for reagent manufacturing, as well as lab space for training. The site is also meant to serve as a commercial hub in the APAC area, with capabilities for in-region sales, marketing, and customer service.


According to the Singapore Economic Development Board's reports, Singapore has approximately 450 biotech and medical technology companies, accounting for 5% of the country's GDP. During 2000 and 2021, the Singaporean government's investment resulted in annual growth of 6% in pharma manufacturing locations. Furthermore, Singapore employs five times as many biomedical researchers per capita as the United States. As a result, organizations like 10x Genomics are looking to set up business in the locality. 


 The company's spokesman was unable to specify the specific amount spent on the facility but said it was part of the company's ongoing commitment to expand manufacturing and operations. 10x Genomics is trying to increase its global reach particularly in the Asia-Pacific area, as it is one of the most rapidly growing healthcare markets in the world. In the first half of 2021, the region accounted for 25 percent of the business's global sales. According to 10x Genomics' expansion in the country, the life sciences sector is an important part of the healthcare economy and seems to have a promising future. The EDB is committed to promoting the sector's innovation and manufacturing operations, which is likely to result in productive employment and business possibilities for Singaporeans. 10x Genomics isn't the only startup in the country wanting to invest in manufacturing new devices. In Singapore, Lonza expanded its mammalian development services by building a new 1800-square-meter facility and 125 new personnel.


 


Weekly Brief

loading
Top 10 Genomics Solutions Companies in Europe/UK – 2022
> <
  • Regulatory Services 2023

    Top Vendors

    Current Issue
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue
  • Regulatory Services 2023

    Top Vendors

    Current Issue
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue

Read Also

The Role of AI in Accurate Medical Writing

Patrik Renblad to Join Cantargia as Chief Financial Officer

Overview of the Life Sciences BPO Market

Dr. Zamaneh Mikhak Joins TFF Pharmaceutical as the New Chief Medical Officer

The Significance of AI in Medical Writing

The Importance of Technology in Multinational Clinical Research

Hepion Pharmaceuticals to Get a Total of $ 3.2 Million in Non-Dilutive Financing

Benefits that Medical Writing Offers

Loading...

Copyright © 2023 Life Sciences Review . All rights reserved. |  Subscribe |  About Us follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/news/singapore-to-grow-into-a-global-hub-of-biotechnology-nwid-670.html